In a bid to relieve immense pressure on the nation's hospital systems, millions of Australians are now eligible for COVID-19 antiviral drugs on the Pharmaceutical Benefits Scheme (PBS).
The decision to expand access comes after the Pharmaceutical Benefits Advisory Committee (PBAC) recommended the changes to the eligibility criteria.